FREQUENTLY ASKED QUESTIONS ABOUT EBOLA VIRUS DISEASE

Size: px
Start display at page:

Download "FREQUENTLY ASKED QUESTIONS ABOUT EBOLA VIRUS DISEASE"

Transcription

1 FREQUENTLY ASKED QUESTIONS ABOUT EBOLA VIRUS DISEASE What is EBOLA? Ebola, previously known as Ebola hemorrhagic fever, is a deadly disease caused by infection with one of the Ebola virus strains. One out of two patients will die from Ebola virus disease if appropriate and prompt medical attention is not provided. Ebola can cause disease in humans and nonhuman primates (monkeys, gorillas, and chimpanzees). Ebola is a rare disease caused by infection with a virus of the family Filoviridae, genus Ebola virus. There are five identified Ebola virus strains. Four of the five have caused disease in humans: Ebola virus (Zaire ebolavirus); Sudan virus (Sudan ebolavirus); Taï Forest virus (Taï Forest ebola virus, formerly Côte d Ivoire ebola virus); and Bundibugyo virus (Bundibugyo ebolavirus). The fifth, Reston virus (Reston ebolavirus), has caused disease in nonhuman primates but not in humans. To know the current burden of EVD, please on any of the following links: WHO: Ebola Virus Disease ( DOH (Philippines) : Ebola ( Ebola FAQ Sub-Topics: Who is a PERSON UNDER INVESTIGATION (PUI) for EBOLA VIRUS DISEASE? How is this different from a PERSON SUSPECTED TO HAVE EBOLA VIRUS DISEASE? What are the signs and symptoms of EBOLA VIRUS DISEASE? How is EBOLA transmitted? What should I do if I am exposed to someone who has EBOLA? Who should I contact if I suspected that I have the signs and symptoms of EBOLA? Is a person who has recovered from EBOLA still contagious? Who are at high risk for getting sick with EBOLA VIRUS DISEASE? What is the treatment for EBOLA VIRUS DISEASE? How do I protect myself from EBOLA? I am a HEALTHCARE WORKER. How do I protect myself?

2 Who is a PERSON UNDER INVESTIGATION (PUI) for EBOLA VIRUS DISEASE? A. Any person arriving in the Philippines from any of the following countries in West Africa namely, Guinea, Liberia, Sierra Leone, Nigeria, and Democratic Republic of Congo--in the past 21 days OR PUI EVD B. Any person who has had contact with another person with confirmed Ebola Virus Disease (EVD). If you fall under any of the above descriptions of a Person Under Investigation, you should call any of the following: DOH National Epidemiology Center (NEC) loc DOH Health Emergency Management Bureau to 1002 If you do not have any symptoms of the Ebola Virus Disease, you will be observed and monitored closely ( home quarantine ) for 21 days. During this period, you will be asked to take your temperature 2x/day, record your temperatures, and watch for any signs and symptoms of illness. You will also be advised to stay at home during the observation period. Should you develop any symptoms, you should inform the above hotlines immediately. (See also the FAQ on Person Suspected to Have Ebola Virus Disease.)

3 How is this different from a PERSON SUSPECTED TO HAVE EBOLA VIRUS DISEASE? EVD A SUSPECT case of EVD is: A PUI who develops signs and symptoms during the 21-day quarantine period OR

4 with epidemiologic risk factors within the past 21 days before the onset of symptoms such as: Contact with blood or other body fluids or human remains of a patient known to have or suspected to have EVD; Residence in or travel to--an area where Ebola virus transmission is active; or Direct handling of bats, rodents, or primates from disease-endemic areas; AND West African countries Ebola virus transmission if currently active: Guinea, Liberia, and Sierra Leone Source of map: "2014 ebola virus epidemic in West Africa simplified" by ZeLonewolf - Own work. Licensed under CC0 via Wikimedia Commons _epidemic_in_west_africa_simplified.svg#mediaviewer/ File:2014_ebola_virus_epide mic_in_west_africa_simplified.svg

5 any person with sudden onset of high fever or any of the following symptoms: Headache Diarrhea Anorexia/loss of appetite Abdominal pain Lethargy Difficulty of swallowing Sore throat Bleeding from gums Aching joints or muscles Bleeding into skin (purpura) Bleeding into eyes or in urine Difficulty in breathing Vomiting, hiccups

6 What are the signs and symptoms of EBOLA VIRUS DISEASE? Signs and symptoms of Ebola include: fever, severe headache, fatigue, muscle pain, weakness, diarrhea, vomiting, abdominal (stomach) pain, and/or unexplained hemorrhage (bleeding or bruising).symptoms may appear anywhere from 2 to 21 days after exposure to Ebola virus, but the average is 8 to 10 days. Recovery from Ebola depends on good supportive clinical care by competent healthcare workers and the patient s immune response. People who recover from Ebola infection develop antibodies that last for at least 10 years, possibly longer. It is not known if people who recover are immune for life or if they can become infected with a different species of Ebola. Some people who have recovered from Ebola have developed long-term complications, such as joint and muscle pain and vision problems.

7 How is EBOLA transmitted? Because the natural reservoir of Ebola virus has not yet been identified, the way in which the virus first appears in a human at the start of an outbreak is unknown. However, researchers believe that the first patient becomes infected through contact with an infected animal, such as a fruit bat or nonhuman primate.

8 When an infection does occur in humans, the virus can be spread in several ways to others: Ebola is spread through direct contact (through broken skin or unprotected mucous membranes in, for example, the eyes, nose, or mouth) Blood or body fluids (including, but not limited to, feces, saliva, sweat, urine, vomit, breast milk, and semen) of a person who is sick with Ebola Objects (like needles and syringes) that have been contaminated with the virus Infected fruit bats or primates (apes and monkeys)

9 Ebola is NOT spread through the air or by water, or in general, by food. However, in Africa, Ebola may be spread as a result of handling bush meat (wild animals hunted for food) and contact with infected bats. There is no evidence that mosquitoes or other insects can transmit Ebola virus. Only a few species of mammals (for example, humans, bats, monkeys, and apes) have shown the ability to become infected with and spread Ebola virus.

10 What should I do if I am exposed to someone who has EBOLA? If you have traveled to an area with an Ebola outbreak or had close contact with a person sick with Ebola ( Person Under Investigation ), you may be at risk if you: Had direct contact with blood or body fluids or items that came into contact with blood or body fluids from a person with Ebola. Touched bats or nonhuman primates (like apes or monkeys) or blood, fluids, or raw meat prepared from these animals. Went into hospitals where Ebola patients were being treated and had close contact with the patients. Touched the body of a person who died of Ebola. You should check for signs and symptoms of Ebola for 21 days. Take your temperature every morning and evening. Watch for other Ebola symptoms, like severe headache, muscle pain, fatigue, vomiting, diarrhea, stomach pain, or unexplained bleeding or bruising. Call your doctor even if you do not have symptoms. The doctor can evaluate your exposure level and any symptoms and consult with public health authorities to determine if actions are needed. If you got sick after you came back from an area with an Ebola outbreak: Get medical care right away if you have a fever, severe headache, fatigue, muscle pain, vomiting, diarrhea, stomach pain, or unexplained bruising or bleeding. Tell your doctor about your recent travel to West Africa or contact with a person who was sick with Ebola and your symptoms BEFORE you go to the doctor s office or emergency room. Calling before you go to your doctor s office or emergency room will help the doctor or emergency room care for you and protect other people who may be in the office or emergency room. Report to DOH NEC ( loc. 2930) or the DOH Health Emergency Management Bureau ( to 1002) the first time you have any signs and symptoms of Ebola infection.

11 Who should I contact if I suspect that I have the signs and symptoms of EBOLA? Signs and symptoms of Ebola include: fever, severe headache, fatigue, muscle pain, weakness, diarrhea, vomiting, abdominal (stomach) pain, an/or unexplained hemorrhage (bleeding or bruising).symptoms may appear anywhere from 2 to 21 days after exposure to Ebola virus, but the average is 8 to 10 days. If you have travelled to any Ebola-affected countries and you have any of the above symptoms, please report to: DOH NEC ( loc. 2930) or the DOH Health Emergency Management Bureau ( to 1002). Is a person who has recovered from EBOLA still contagious? Once people recover from Ebola, they can no longer spread the virus to people in the community. However, because the Ebola virus can stay in the semen after recovery, men should abstain from sex (including oral sex) for at least three months. If abstinence is not possible, condoms may help prevent the spread of the disease. There is no evidence that people can get sick from the Ebola virus through sex (or oral sex) before symptoms appear. Who are at high risk for getting sick with EBOLA VIRUS DISEASE? Healthcare providers caring for Ebola patients, and the family and friends who are in close contact with Ebola patients are at the highest risk of getting sick because they may come in contact with the infected blood and body fluids of sick patients. During outbreaks of Ebola, the disease can spread quickly within healthcare settings (such as a clinic or hospital). Exposure to Ebola viruses can occur in healthcare settings where health workers are not wearing appropriate protective clothing including masks, gowns, gloves, eye goggles, and impermeable footwear.

12 What is the treatment for EBOLA VIRUS DISEASE? No FDA-approved vaccine or medicine (e.g., antiviral drug) is available for Ebola. Symptoms of Ebola are treated as they appear. The following basic interventions, when used early, can significantly improve the chances of survival: Providing intravenous fluids and balancing electrolytes (body salts); Maintaining oxygen status and blood pressure; and, Treating other infections if they occur. Experimental vaccines and treatments for Ebola are under development, but they have not yet been fully tested for safety or effectiveness. Recovery from Ebola depends on good supportive care and the patient s immune response. People who recover from Ebola infection develop antibodies that last for at least 10 years, possibly longer. It isn t known if people who recover are immune for life or if they can become infected with a different species of Ebola. Some people who have recovered from Ebola have developed long-term complications, such as joint and vision problems.

13 How do I protect myself from EBOLA? If you travel to, work in, or are in an area affected by an Ebola outbreak, make sure to do the following: Practice careful hygiene. For example, wash your hands with soap and water or an alcohol-based hand sanitizer and avoid contact with blood and body fluids. Do not handle items that may have come in contact with an infected person s blood or body fluids (such as clothes, bedding, needles, and medical equipment). Avoid funeral or burial rituals that require handling the body of someone who has died from Ebola. Avoid contact with bats and nonhuman primates or blood, fluids, and raw meat prepared from these animals. Avoid facilities in West Africa where Ebola patients are being treated. The U.S. embassy or consulate is often able to provide advice on facilities. After you return, monitor your health for 21 days and seek medical care immediately if you develop symptoms of Ebola.

14 I am a HEALTHCARE WORKER. How do I protect myself? New guidelines from the Centers for Disease Control and Protection call for head-to-toe protection for health workers treating Ebola patients. (Photo: Janet Loehrke, USA TODAY, SOURCE: Centers for Disease Control and Prevention) Link: Healthcare workers who may be exposed to people with Ebola should follow these steps: First of all, get trained and retrained on proper infection prevention and control procedures in managing patients with Ebola virus disease. Wear appropriate Personal Protective Equipment when caring for suspected or confirmed cases of Ebola Virus Disease. Practice proper infection control and sterilization measures. Isolate patients with Ebola from other patients. Avoid direct contact with the bodies of people who have died from Ebola. Notify health officials if you have had direct contact with the blood or body fluids, such as but not limited to, feces, saliva, urine, vomit, and semen of a person who is sick with Ebola. The virus can enter the body through broken skin or unprotected mucous membranes in, for example, the eyes, nose, or mouth.

15 For more information, please go to: Clinical Care of Ebola Virus Disease, RITM DOH Interim Guidelines Prepared by: UP Manila Task Force on Ebola Preparedness & Response

Ebola Q & A. # Question Answer Modified

Ebola Q & A. # Question Answer Modified Ebola Q & A # Question Answer Modified 1 Are U.S. hospitals ready to care for patients with Ebola virus disease (EVD)? Yes any U.S. hospital that is following CDC's infection control recommendations(http://www.cdc.gov/vhf/ebola/hcp/infectionprevention-and-control-recommendations.html)

More information

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2.

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2. Training Bulletin Ebola Virus Disease October 24, 2014 Issue Number 114 - version 2.1 Emergency Health Services Branch Ministry of Health and Long-Term Care Training Bulletin, Issue Number 114 version

More information

PROTECT YOURSELF PROTECT YOUR FAMILY PROTECT YOUR COMMUNITY from Ebola

PROTECT YOURSELF PROTECT YOUR FAMILY PROTECT YOUR COMMUNITY from Ebola PROTECT YOURSELF PROTECT YOUR FAMILY PROTECT YOUR COMMUNITY from Ebola gchv Training on EBOLA Flipbook and IPC September 2014 And partners Liberia Guinea Sierra Leone 2 Ebola Things Everyone Should Know

More information

DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88%

DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88% DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88% ETYMOLOGY First recorded outbreak at,yambuku in democratic republic of congo (EBOLA RIVER)

More information

(Public Health) Management of Ebola Disease. Aura Timen, MD, PhD. National Coordination Centre for Communicable Disease Control (LCI) CIb

(Public Health) Management of Ebola Disease. Aura Timen, MD, PhD. National Coordination Centre for Communicable Disease Control (LCI) CIb (Public Health) Management of Ebola Disease Aura Timen, MD, PhD National Coordination Centre for Communicable Disease Control (LCI) CIb Het hoe,wat en wie van de LCI Everybody knows that pestilences have

More information

Clinical Case Management Guidelines of Ebola Virus Disease (EVD)

Clinical Case Management Guidelines of Ebola Virus Disease (EVD) Clinical Case Management Guidelines of Ebola Virus Disease (EVD) 1. Introduction Ebola Virus Disease (earlier known as Ebola hemorrhagic fever) is a severe, often fatal disease in humans and nonhuman primates

More information

Page 1 of 6 Interim Guidance for Emergency Medical Services (EMS) Systems and 9-1-1 Public Safety Answering Points (PSAPs) for Management of Patients Who Present With Possible Ebola Virus Disease in the

More information

A surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014

A surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014 A surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014 Jean Marie Vianney Namahoro Postgraduate student Stellenbosch University Fakulteit Geneeskunde en Gesondheidswetenskappe Faculty of Medicine

More information

EBOLA AND PREPAREDNESS AT DENVER HEALTH. Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health

EBOLA AND PREPAREDNESS AT DENVER HEALTH. Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health EBOLA AND PREPAREDNESS AT DENVER HEALTH Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health Denver Health and Hospital September 18, 2015 Agenda Background on Ebola Overview of

More information

Ebola Facts. October 14, 2014

Ebola Facts. October 14, 2014 Ebola Facts October 14, 2014 Symptoms of Ebola Initial symptoms are nonspecific - may include fever, chills, myalgias, and malaise. Patients can progress to develop gastrointestinal symptoms: severe watery

More information

Chicago Ebola Preparedness Update. Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015

Chicago Ebola Preparedness Update. Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015 Chicago Ebola Preparedness Update Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015 Agenda Ebola Overview Crisis in West Africa Symptoms and transmission

More information

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT HIGHLIGHTS EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT SITUATION REPORT 3 DECEMBER 2014 There have been 17 145 reported cases of Ebola virus disease (EVD), with 6070 reported deaths. Case incidence

More information

RE: CIRCULAR 02/14 EBOLA - SOUTH AMERICAN COUNTRIES

RE: CIRCULAR 02/14 EBOLA - SOUTH AMERICAN COUNTRIES RE: CIRCULAR 02/14 EBOLA - SOUTH AMERICAN COUNTRIES Dear Sirs, Due to the outbreak of Ebola and all the implications that this could have in our area of influence, the members of SAPIC have discussed this

More information

Surveillance strategy during Phase 3 of the Ebola response

Surveillance strategy during Phase 3 of the Ebola response EMERGENCY GUIDANCE Surveillance strategy during Phase 3 of the Ebola response 5 November 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: WHO Ebola Response Team. Ebola virus disease among children

More information

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication Guide each time you get more ribavirin tablets. There may

More information

Announcements. Please mute your phones and DO NOT place us on hold. Press *6 to mute/unmute your phone.

Announcements. Please mute your phones and DO NOT place us on hold. Press *6 to mute/unmute your phone. 1 Announcements Register for the Epi-Tech Trainings: 1. Log-on or Request log-on ID/password: https://tiny.army.mil/r/zb8a/cme 2. Register for Epi-Tech Surveillance Training: https://tiny.army.mil/r/leaid/epitechfy15

More information

Survey of Private Sector Pharmacies and Medicine Stores in Montserrado County, Liberia

Survey of Private Sector Pharmacies and Medicine Stores in Montserrado County, Liberia Survey of Private Sector Pharmacies and Medicine Stores in Montserrado County, Liberia Context: The worst Ebola Virus Disease (EVD) outbreak ever recorded in West Africa 1 revealed that health systems

More information

Classroom Discussion Guide on Ethics and Public Health Emergencies

Classroom Discussion Guide on Ethics and Public Health Emergencies Classroom Discussion Guide on Ethics and Public Health Emergencies This guide provides discussion questions and topics based on the Presidential Commission for the Study of Bioethical Issues report, Ethics

More information

IHR Emergency Committee on the 2014 / 15 Ebola outbreak in West Africa

IHR Emergency Committee on the 2014 / 15 Ebola outbreak in West Africa IHR Emergency Committee on the 2014 / 15 Ebola outbreak in West Africa April, 2015 Dr Peter Gaturuku Capacity Building and Training Health Security and Emergencies Cluster WHO Regional Office for Africa,

More information

CDC Support for Exit Screening and Lessons Learned for Preparedness

CDC Support for Exit Screening and Lessons Learned for Preparedness CDC Support for Exit Screening and Lessons Learned for Preparedness Andrew Demma, MS International Assistance Lead Global Migration Task Force Centers for Disease Control and Prevention National Center

More information

Enoxaparin (Lovenox )

Enoxaparin (Lovenox ) What is enoxaparin (Lovenox )? Enoxaparin is also called Lovenox Enoxaparin is an anticoagulant, or blood thinner, that works to prevent blood clots from forming in your body or treat blood clots after

More information

Ebola Disease Facts. For Community and Household Health. Prepared for the Liberia Annual Conference of the United Methodist Church

Ebola Disease Facts. For Community and Household Health. Prepared for the Liberia Annual Conference of the United Methodist Church Ebola Disease Facts For Community and Household Health Prepared for the Liberia Annual Conference of the United Methodist Church by Richard A. Nisbett A project of The General Board of Discipleship The

More information

Ebola by the Numbers: Not a Small-scale Killer Anymore

Ebola by the Numbers: Not a Small-scale Killer Anymore Ebola by the Numbers: Not a Small-scale Killer Anymore Ebola in West Africa Previously confined to Central African countries Emerged in Guinea at end of 2013 Source: Feldmann & Geisbert, Lancet 2011 Two

More information

EBOLA SITUATION REPORT

EBOLA SITUATION REPORT EBOLA SITUATION REPORT 30 MARCH 2016 SUMMARY The International Health Regulations (2005) Emergency Committee regarding Ebola virus disease (EVD) in West Africa met for a ninth time on 29 March. On the

More information

Guidelines for the Medical Clearance of Designated Ebola Caregivers in US Hospitals

Guidelines for the Medical Clearance of Designated Ebola Caregivers in US Hospitals Guidelines for the Medical Clearance of Designated Ebola Caregivers in US Hospitals American College of Occupational and Environmental Medicine Medical Center Occupational Health Section Prepared by the

More information

Sudan Ebola Virus. genesig Standard Kit. Nucleoprotein (np) gene. 150 tests. Primerdesign Ltd. For general laboratory and research use only

Sudan Ebola Virus. genesig Standard Kit. Nucleoprotein (np) gene. 150 tests. Primerdesign Ltd. For general laboratory and research use only TM Primerdesign Ltd Sudan Ebola Virus Nucleoprotein (np) gene genesig Standard Kit 150 tests For general laboratory and research use only 1 Introduction to Sudan Ebola Virus Ebola viruses are the causative

More information

SITUATION REPORT EBOLA RESPONSE RESPONSE ROADMAP SITUATION ROADMAP REPORT

SITUATION REPORT EBOLA RESPONSE RESPONSE ROADMAP SITUATION ROADMAP REPORT EBOLA RESPONSE RESPONSE ROADMAP SITUATION ROADMAP REPORT SITUATION REPORT HIGHLIGHTS 31 DECEMBER 2014 There have been 20 206 reported cases of Ebola virus disease, with 7905 reported deaths. Reported case

More information

Selection and use of Ebola in vitro diagnostic (IVD) assays

Selection and use of Ebola in vitro diagnostic (IVD) assays EMERGENCY GUIDANCE Selection and use of Ebola in vitro diagnostic (IVD) assays June 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the material

More information

arxiv: v4 [q-bio.pe] 2 Sep 2014

arxiv: v4 [q-bio.pe] 2 Sep 2014 Pre-print version of manuscript published at PLOS Currents Outbreaks (2 September 2014) Estimating the reproduction number of Ebola virus (EBOV) during the 2014 outbreak in West Africa Christian L. Althaus

More information

Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation

Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation Design Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation CLINICAL TRIALS Clinical Trials 2016, Vol. 13(1) 66 72 Ó The Author(s)

More information

R&D for potential vaccines for the Ebola virus

R&D for potential vaccines for the Ebola virus R&D for potential vaccines for the Ebola virus Update 4 March 2015 Roberto Bertollini MD MPH Chief Scientist and WHO Representative to the EU Gathering knowledge Since August 2014, series of consultations

More information

Reconsidering the Ethical Permissibility of the use of Unregistered Interventions against Ebola Virus Disease

Reconsidering the Ethical Permissibility of the use of Unregistered Interventions against Ebola Virus Disease Reconsidering the Ethical Permissibility of the use of Unregistered Interventions against Ebola Virus Disease Presented by: International Bioethics Retreat Paris, 2015 Dr. Thomas Foreman, MPIA, MA, DHCE

More information

EBOLA RESPONSE IN LIBERIA COMMUNITY HEALTH VOLUNTEERS

EBOLA RESPONSE IN LIBERIA COMMUNITY HEALTH VOLUNTEERS EBOLA RESPONSE IN LIBERIA COMMUNITY HEALTH VOLUNTEERS OXFAM NOVIB CASE MAY 2015 SUMMARY HALTING EBOLA BY WINNING COMMUNITIES TRUST When Ebola hit Liberia in 2014, an atmosphere of fear and confusion contributed

More information

Zaire Ebola Virus. genesig Advanced Kit. Nucleoprotein (np) gene. 150 tests. Primerdesign Ltd. For general laboratory and research use only

Zaire Ebola Virus. genesig Advanced Kit. Nucleoprotein (np) gene. 150 tests. Primerdesign Ltd. For general laboratory and research use only TM Primerdesign Ltd Zaire Ebola Virus Nucleoprotein (np) gene genesig Advanced Kit 150 tests For general laboratory and research use only 1 Introduction to Zaire Ebola Virus Ebola viruses are the causative

More information

Using Complete Blood Cell Counts to Diagnose Disease

Using Complete Blood Cell Counts to Diagnose Disease Physiology 2 Redwood High School Name Class Period Using Complete Blood Cell Counts to Diagnose Disease Background A healthy adult has about 4.5 to 5 million red blood cells and approximately 8,000 white

More information

A GUIDE TO THIS REFLECTIONS B RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE

A GUIDE TO THIS REFLECTIONS B RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE A GUIDE TO THIS REFLECTIONS B327-02 RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE Do you have breast cancer that has spread to outside the breast? Has your tumor tested positive for

More information

The Role of Public Health Practitioners: in Achieving Healthier and Safer World

The Role of Public Health Practitioners: in Achieving Healthier and Safer World The Role of Public Health Practitioners: in Achieving Healthier and Safer World Prof. Wiku Adisasmito, DVM, M.Sc, PhD Global Health Security Agenda One Health Approach Bandung, October 21, 2015 The Emerging

More information

Study on Public Knowledge, Attitudes, and Practices Relating to Ebola Virus Disease (EVD) Prevention and Medical Care in Sierra Leone

Study on Public Knowledge, Attitudes, and Practices Relating to Ebola Virus Disease (EVD) Prevention and Medical Care in Sierra Leone Study on Public Knowledge, Attitudes, and Practices Relating to Ebola Virus Disease (EVD) Prevention and Medical Care in Sierra Leone September 2014 Table of Contents Table of Contents... 2 Foreword...4

More information

Information and resources for African Americans living with multiple myeloma and their caregivers

Information and resources for African Americans living with multiple myeloma and their caregivers For African Americans living with Multiple Myeloma Information and resources for African Americans living with multiple myeloma and their caregivers Standing in the Gaap: An initiative created to help

More information

Preparations for Ebola Vaccine Deployment

Preparations for Ebola Vaccine Deployment Preparations for Ebola Vaccine Deployment Ebola vaccine and vaccination - Session 8 Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) Geneva, 14 16 April 2015 Dr Marie-Pierre Preziosi,

More information

Atlantic County Division of Public Health Questions and Answers about Cyanide

Atlantic County Division of Public Health Questions and Answers about Cyanide What cyanide is Atlantic County Division of Public Health Questions and Answers about Cyanide Cyanide is a rapidly acting, potentially deadly chemical that can exist in various forms. Cyanide can be a

More information

WFP West Africa Regional Bureau REGIONAL SPECIAL OPERATION SO

WFP West Africa Regional Bureau REGIONAL SPECIAL OPERATION SO WFP West Africa Regional Bureau REGIONAL SPECIAL OPERATION SO 200773 Country: West Africa Regional Bureau (OMD) Ghana, Guinea, Sierra Leone, and Liberia Type of project: Special Operation Title: Logistics

More information

LEARN. about. Please see Important Safety Information on pages 3-5 and enclosed full Prescribing Information.

LEARN. about. Please see Important Safety Information on pages 3-5 and enclosed full Prescribing Information. LEARN about on pages 3-5 and enclosed 2 3? What is ZARXIO (filgrastim-sndz)? ZARXIO is a man-made form of granulocyte colony-stimulating factor (G-CSF) called filgrastim. G-CSF is a substance produced

More information

Analysis of Ebola Epidemic Outbreaks in West Africa

Analysis of Ebola Epidemic Outbreaks in West Africa IOSR Journal of Mathematics (IOSR-JM) e-issn: 2278-5728, p-issn: 2319-765X. Volume 13, Issue I Ver. V (Jan. - Feb. 2017), PP 30-40 www.iosrjournals.org Analysis of Ebola Epidemic Outbreaks in West Africa

More information

Biosafety Checklist. 07-BiosafetyChecklist-LTC-SOP-v2.0-17Feb of 6

Biosafety Checklist. 07-BiosafetyChecklist-LTC-SOP-v2.0-17Feb of 6 Title: Biosafety Checklist Origination Date: 31 Jan 1997 Total Pages: 5 Effective Date: 17 Feb 2012 SOP Number LTC-SOP-07 v2.0 Supersedes SOP Written By: ACTG/IMPAACT Lab Tech Committee Dated: 01 Jun 2004

More information

Laboratory Research Ethics, Conduct and Safety

Laboratory Research Ethics, Conduct and Safety Laboratory Research Ethics, Conduct and Safety Biohazards and Biosafety Guidelines & Standards Human Pathogens Public Health Agency of Canada Canadian Food Inspection Agency Animal Pathogens Definition:

More information

Manatee County Sheriff s Office PROPERTY AND EVIDENCE

Manatee County Sheriff s Office PROPERTY AND EVIDENCE Manatee County Sheriff s Office PROPERTY AND EVIDENCE 1 What Every LEO Should Know About DNA Evidence 2 Similar to fingerprints DNA is similar to fingerprint analysis in how matches are determined. When

More information

UNCLASSIFIED OPERATION UNITED ASSISTANCE SUMMARY Z October 14

UNCLASSIFIED OPERATION UNITED ASSISTANCE SUMMARY Z October 14 OPERATION UNITED ASSISTANCE SUMMARY 29 0600Z October 14 (U) Weather at a Glance Date Range: 25OCT 27OCT Senegal Deaths: +0 (0 total) Cases: +0 (1 total) Guinea Deaths: +22 (926 total) Cases: +13 (1553

More information

Biosecurity in Animal Production Farms

Biosecurity in Animal Production Farms Biosecurity in Animal Production Farms ADFCA-008-01-2011-01 Biosecurity in Animal Production Farms Definition of Biosecurity: Biosecurity is a number of measures used to prevent disease causative infectious

More information

Treatment: Nutrition and Medication

Treatment: Nutrition and Medication INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE Treatment: Nutrition and Medication While there is no cure for Crohn s disease, there are a number of options to help treat it. The goals of treatment

More information

AFRICAN UNION (AU) Topic B: Ebola and Health Issues

AFRICAN UNION (AU) Topic B: Ebola and Health Issues AFRICAN UNION (AU) Topic B: Ebola and Health Issues NUMUN XII 2 Introduction Within the past couple of years, there have been many outbreaks of the deadly human disease Ebola. Most of the outbreaks have

More information

Good Agricultural Practices (GAPs)

Good Agricultural Practices (GAPs) Good Agricultural Practices (GAPs) Slide 1: Cover slide Notes to instructor: Welcome participants to this training session. If this session is part of a larger workshop, tell the participants in this next

More information

THE EBOLA VIRUS; PRELIMINARY THEORETICAL MOLECULAR IMAGING CONSIDERATIONS GIVEN TO THE POTENTIAL IMMUNOSTIMULATORY EFFECTS - ALLOGENEIC LYMPHOCYTES

THE EBOLA VIRUS; PRELIMINARY THEORETICAL MOLECULAR IMAGING CONSIDERATIONS GIVEN TO THE POTENTIAL IMMUNOSTIMULATORY EFFECTS - ALLOGENEIC LYMPHOCYTES THE EBOLA VIRUS; PRELIMINARY THEORETICAL MOLECULAR IMAGING CONSIDERATIONS GIVEN TO THE POTENTIAL IMMUNOSTIMULATORY EFFECTS - ALLOGENEIC LYMPHOCYTES (Letter) Stewart, R. January, 2015 Abstract: There is

More information

Package leaflet: Information for the user. HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion. Human albumin

Package leaflet: Information for the user. HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion. Human albumin Package leaflet: Information for the user HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion Human albumin Read all of this leaflet carefully before you start using this medicine because it contains important

More information

How to safely ship human blood samples from suspected Ebola cases within a country by road, rail and sea

How to safely ship human blood samples from suspected Ebola cases within a country by road, rail and sea INTERIM GUIDELINE How to safely ship human blood samples from suspected Ebola cases within a country by road, rail and sea 2014 Step 1: Before handling the sample, prepare all shipping equipment Step 1a:

More information

Transmitted from animals to humans. Transmitted humans-to-human by body fluid contact

Transmitted from animals to humans. Transmitted humans-to-human by body fluid contact April 2016 Highly contagious sheathed virus Transmitted from animals to humans Transmitted humans-to-human by body fluid contact Mortality rate as high as 90% Incubation period is 21 days March 2014 Ebola

More information

TRAINING GOPACKAGE FOR EBOLA PRE-DEPLOYMENT PARTICIPANT HANDBOOK

TRAINING GOPACKAGE FOR EBOLA PRE-DEPLOYMENT PARTICIPANT HANDBOOK TRAINING GOPACKAGE FOR EBOLA PRE-DEPLOYMENT PARTICIPANT HANDBOOK WHO Library Cataloguing-in-Publication Data: Go training: package for Ebola pre-deployment. Contents: Participant handbook Ebola virus disease

More information

STATUS OF REVIEWS, AUTHORIZATIONS AND OVERSIGHT FOR CLINICAL TRIALS IN THE WHO AFRICAN REGION. Technical Document

STATUS OF REVIEWS, AUTHORIZATIONS AND OVERSIGHT FOR CLINICAL TRIALS IN THE WHO AFRICAN REGION. Technical Document 15 June 2017 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-seventh session Victoria Falls, Republic of Zimbabwe, 28 August 1 September 2017 Provisional agenda item 17 STATUS OF REVIEWS, AUTHORIZATIONS

More information

Section 1: SUBSTANCE IDENTIFICATION AND SUPPLIER

Section 1: SUBSTANCE IDENTIFICATION AND SUPPLIER Safety Data Sheet Copper Sulphate Revised: 29/07/2016 Section 1: SUBSTANCE IDENTIFICATION AND SUPPLIER Product Name: Other names: Chemical Formula: Product Code: Recommended Use: Company Identification:

More information

Where are we heading?

Where are we heading? Unit Three: Where are we heading? Outline 2Lesson Unit1.2 Unit 3: Outline Unit 1: What is an infectious disease and why do we care? Unit 2: What does it mean to have an infectious disease? Unit 3: When

More information

Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease

Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease INFECTIOUS DISEASE/ORIGINAL RESEARCH Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease Adam C. Levine, MD, MPH*; Pranav

More information

AVOID FOODBORNE ILLNESS

AVOID FOODBORNE ILLNESS What is food safety? Food Safety at the Market Handling Preparation Storage Allison Smathers Tobacco Trust Fund Commission February 11, 2011 AVOID FOODBORNE ILLNESS Foodborne illness in the US -in- High

More information

Daniel J. Mollura, MD Tara N. Palmore, MD Les R. Folio, DO David A. Bluemke, MD, PhD. Original Research n Special Report

Daniel J. Mollura, MD Tara N. Palmore, MD Les R. Folio, DO David A. Bluemke, MD, PhD. Original Research n Special Report Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Original Research

More information

Modeling the Impact of Ebola and Bushmeat Hunting on Western Lowland Gorillas

Modeling the Impact of Ebola and Bushmeat Hunting on Western Lowland Gorillas EcoHealth (Ó 2007) DOI: 10.1007/s10393-007-0096-2 Ó 2007 EcoHealth Journal Consortium Original Contribution Modeling the Impact of Ebola and Bushmeat Hunting on Western Lowland Gorillas Carol Rizkalla,

More information

Approved by CAC Board August 18, 2011

Approved by CAC Board August 18, 2011 CALIFORNIA AVOCADO INDUSTRY Good harvesting Practices (GhP) Manual Field Harvest The California avocado industry, composed of 5,000 growers throughout the state, is dedicated to providing consumers with

More information

HEALTH AND HYGIENE Safety Data Sheet

HEALTH AND HYGIENE Safety Data Sheet NOTE: To further assist with the interpretation of the MSDS, explanatory notes have been added in italics SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier

More information

Learn more about why severe RSV disease APPROVED USE

Learn more about why severe RSV disease APPROVED USE Learn more about why severe RSV disease can turn a welcome home into a welcome back to the hospital APPROVED USE SYNAGIS (palivizumab) is a prescription medication that is used to help prevent a serious

More information

SCHOOL OF PUBLIC HEALTH COLLEGE OF HEALTH SCIENCES UNIVERSITY OF GHANA KNOWLEDGE, ATTITUDES AND PERCEPTIONS OF COMMUNITY

SCHOOL OF PUBLIC HEALTH COLLEGE OF HEALTH SCIENCES UNIVERSITY OF GHANA KNOWLEDGE, ATTITUDES AND PERCEPTIONS OF COMMUNITY SCHOOL OF PUBLIC HEALTH COLLEGE OF HEALTH SCIENCES UNIVERSITY OF GHANA KNOWLEDGE, ATTITUDES AND PERCEPTIONS OF COMMUNITY MEMBERS TOWARD THE EBOLA VIRUS DISEASE (EVD) IN PAGA, KASENA-NANKANA WEST DISTRICT

More information

UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES

UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES Biodefense solutions to protect our nation Forward genomic surveillance advances DoD biomedical research toward combating high-consequence

More information

Laboratory Research Conduct & Safety: Biohazards and Biosafety. Environmental Health & Safety

Laboratory Research Conduct & Safety: Biohazards and Biosafety. Environmental Health & Safety Laboratory Research Conduct & Safety: Biohazards and Biosafety www.mcgill.ca/ehs/laboratory/biosafety/manual Regulations Human Pathogens Public Health Agency of Canada Canadian Food Inspection Agency Animal

More information

Obtain a set of DNA sequences that includes the reference sample from Guinea and 15 Ebola DNA sequences from samples of patients in Sierra Leone.

Obtain a set of DNA sequences that includes the reference sample from Guinea and 15 Ebola DNA sequences from samples of patients in Sierra Leone. INTRODUCTION In this activity, you will analyze sequences of Ebola viruses isolated from patients in Sierra Leone during the Ebola outbreak of 2013 2016 to track the virus spread. Do you have what it takes

More information

The response of research: from the field to the lab. K. Victoir PhD

The response of research: from the field to the lab. K. Victoir PhD The response of research: from the field to the lab K. Victoir PhD Outline Responses to the Ebola outbreak: a nations response (France) and an institutional response (IP) Overview of the Field actions

More information

Ebola: Working Toward Treatments and Vaccines

Ebola: Working Toward Treatments and Vaccines Claire Sykes and Miriam Reisman The deadly and highly infectious Ebola virus was discovered in 1976 in Yambuku in the Democratic Republic of Congo, 60 miles from the river after which it was named. 1 But

More information

Louise Gresham PhD MPH Fondation Mérieux. Ebola Panel IOM 19 November 2014

Louise Gresham PhD MPH Fondation Mérieux. Ebola Panel IOM 19 November 2014 Louise Gresham PhD MPH Fondation Mérieux Ebola Panel IOM 19 November 2014 WHO Ebola Situation Report 14 November 2014 Country Cases Deaths Liberia 6878 2812 Sierra Leone 5586 1187 Guinea 1919 1166 Mali

More information

MAGNESIUM SULFATE ANHYDROUS MATERIAL SAFETY DATA SHEET

MAGNESIUM SULFATE ANHYDROUS MATERIAL SAFETY DATA SHEET MAGNESIUM SULFATE ANHYDROUS MATERIAL SAFETY DATA SHEET Hospital Marketing Services Co. Inc. 1-800-786-5094 Fax: (203) 723-7248 162 Great Hill Rd. Industrial Park P.O. Box 1217 Naugatuck, CT 06770 www.hmsmedical.com

More information

EBOLA crisis management In GUINEA

EBOLA crisis management In GUINEA Antoine Peigney; former international director at French Red Cross EBOLA crisis management In GUINEA Place Logo of your Company here (left-aligned, same height (1.2 cm), on line with EUROSAFE logo) and

More information

Tropical Medicine & International Health

Tropical Medicine & International Health MSF Field Research Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes Authors Citation DOI Publisher Journal Rights Dallatomasinas, Silvia; Crestani, Rosa; Squire, James

More information

Policies Concerning Survival Surgery of Mice

Policies Concerning Survival Surgery of Mice Policies Concerning Survival Surgery of Mice Date approved: October 25, 2016 Purpose This document details the minimum standards for survival (recovery) surgery in all laboratory rodent species. Responsibility

More information

Ebola Virus Disease. BMH Medical Journal 2015;2(1):9-13 Review Article

Ebola Virus Disease. BMH Medical Journal 2015;2(1):9-13 Review Article BMH Medical Journal 2015;2(1):9-13 Review Article Ebola Virus Disease PV Bhargavan, MD, FRCP, FIMSA 1, PV Shiji, MD 2, Jare Jagannath Udhavrao 3, Nagaraj Desai 3 1 Baby Memorial Hospital, Kozhikode, Kerala,

More information

Thermal Imaging for Detecting Potential SARS Infection

Thermal Imaging for Detecting Potential SARS Infection Thermal Imaging for Detecting Potential SARS Infection R. James Seffrin, Director Infraspection Institute Burlington, NJ Presented at: National Conference on Thermal Imagers for Fever Screening - Selection,

More information

Lead is a metal that can have harmful

Lead is a metal that can have harmful Lead Lead is a metal that can have harmful effects on the human body. It can be found in many products, including lead-based paints, lead solder, electrical fittings and conduits, tank linings, plumbing

More information

Hazards Occur: Foodborne Illness Statistics. Pathogens Commonly Associated with Fresh Produce: How Can They Be Controlled?

Hazards Occur: Foodborne Illness Statistics. Pathogens Commonly Associated with Fresh Produce: How Can They Be Controlled? Pathogens Commonly Associated with Fresh Produce: How Can They Be Controlled? David Nyachuba, Ph.D. Assistant Professor, Department of Nutrition, UMass Amherst Director of UMass Extension Food Safety Education

More information

One Year Later, Where Does the U.S. Response to Ebola Stand?

One Year Later, Where Does the U.S. Response to Ebola Stand? One Year Later, Where Does the U.S. Response to Ebola Stand? Kaiser Family Foundation, Washington, DC Jen Kates, PhD Vice President & Director, Global Health & HIV Policy Kaiser Family Foundation jkates@kff.org

More information

Ammonia solution, aqueous ammonia, ammonia water, Spirits of Hartshorn. Chemical Name CAS # RTEC #

Ammonia solution, aqueous ammonia, ammonia water, Spirits of Hartshorn. Chemical Name CAS # RTEC # M A T E R I A L S A F E T Y D A T A S H E E T SECTION I. PRODUCT IDENTIFICATION WESTERN FARM SERVICE 3705 W. Beechwood Ave. P.O. Box 1168 Fresno, CA 93715 (209) 436-0450 FAX (209)436-0515 MATERIAL SAFETY

More information

Insertion of Skin Tunnelled Central Venous Catheter (STC)

Insertion of Skin Tunnelled Central Venous Catheter (STC) Insertion of Skin Tunnelled Central Venous Catheter (STC) This leaflet explains more about STC insertion, including the benefits, risks and any alternatives and what you can expect when you come to hospital.

More information

Asymptomatic infection and family contact patterns in households of Ebola Virus Disease survivors, Sierra Leone 2015

Asymptomatic infection and family contact patterns in households of Ebola Virus Disease survivors, Sierra Leone 2015 Asymptomatic infection and family contact patterns in households of Ebola Virus Disease survivors, Sierra Leone 2015 Data Creators LSHTM: Judith R. Glynn;* Hilary Bower, Catherine Houlihan (laboratory

More information

Safety Data Sheet European Format

Safety Data Sheet European Format Safety Data Sheet European Format 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Preparation Date 26-Jul-2007 Revision Date 09-Sep-2008 Revision Number 3 Product Name Common

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET Issue Date: 1/1/2015 Version: 2.0 Section 1 Product Name Product Use Product and Company Information ProKure D Deodorizing delivery system (pouch) for the generation of chlorine

More information

Deciphering ethical assumptions about Stepped-Wedge Designs: The case of Ebola vaccine research

Deciphering ethical assumptions about Stepped-Wedge Designs: The case of Ebola vaccine research Deciphering ethical assumptions about Stepped-Wedge Designs: The case of Ebola vaccine research A. Doussau, C. Grady SCT, Montreal, May 2016 The views expressed are my own and do not represent the views

More information

MODEL EXPOSURE CONTROL PLAN

MODEL EXPOSURE CONTROL PLAN MODEL EXPOSURE CONTROL PLAN The Model Exposure Control Plan is intended to serve as an employer guide to the OSHA Bloodborne Pathogens standard. A central component of the requirements of the standard

More information

Management of Ebola virus disease: is environmental decontamination effective?

Management of Ebola virus disease: is environmental decontamination effective? Management of Ebola virus disease: is environmental decontamination effective? Short title: Clinical decontamination of Ebola virus Walker NF 1, Youkee D 2, Brown CS 3, Lado M 3, Johnson O 3. 1 Department

More information

Laboratory Research Conduct & Safety: Biohazards and Biosafety. Environmental Health & Safety

Laboratory Research Conduct & Safety: Biohazards and Biosafety. Environmental Health & Safety Laboratory Research Conduct & Safety: Biohazards and Biosafety Regulations Public Health Agency of Canada Canadian Food Inspection Agency Human Pathogens Animal Pathogens 2010: Containment Standards for

More information

Diagnostics: Learning from successful experiences which made it to market. Mark Miller, MD Chief Medical Officer biomérieux France

Diagnostics: Learning from successful experiences which made it to market. Mark Miller, MD Chief Medical Officer biomérieux France Diagnostics: Learning from successful experiences which made it to market Mark Miller, MD Chief Medical Officer biomérieux France Diagnostics: Learning from unsuccessful experiences which almost made it

More information

MATERIAL SAFETY DATA SHEET POLYURETHANE CONFORMAL COATING

MATERIAL SAFETY DATA SHEET POLYURETHANE CONFORMAL COATING Report Date : 2/0/2011 MATERIAL SAFETY DATA SHEET 1 IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING PRODUCT NAME PRODUCT NO. APPLICATION SUPPLIER EMERGENCY TELEPHONE PROPER SHIPPING

More information

For a full listing of nonmedicinal ingredients see Part 1 of the product monograph. PART III: CONSUMER INFORMATION

For a full listing of nonmedicinal ingredients see Part 1 of the product monograph. PART III: CONSUMER INFORMATION PART III: CONSUMER INFORMATION AVONEX PS (interferon beta-1a) prefilled syringe AVONEX PEN (interferon beta-1a) prefilled autoinjector This leaflet is part III of a three-part "Product Monograph" published

More information